Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 77, 2022 - Issue 6
90
Views
4
CrossRef citations to date
0
Altmetric
Research Article

SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second

ORCID Icon, , , , , , & show all

References

  • WHO. Weekly epidemiological update on COVID-19-25 May 2021 [Internet]. [cited 2021 Jun 1]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—25-may-2021.
  • Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
  • Sciensano. COVID-19 surveillance: frequently asked questions [Internet]. [cited 2021 Sep 6]. Available from: https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_FAQ_FR_final.pdf.
  • The Health System Response Monitor (HSRM). Policy responses for Belgium [Internet]. [cited 2021 May 18]. Available from: https://www.covid19healthsystem.org/countries/belgium/livinghit.aspx?Section=3.3Maintainingessentialservices&Type=Section.
  • Mutambudzi M, Niedwiedz C, MacDonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020;78(5):307–314.
  • McCarthy CV, Sandmann FG, Jit M, et al. Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection. J Hosp Infect. 2021;111:205–207.
  • Hoernke K, Djellouli N, and Andrews L, et al. Frontline healthcare workers’ experiences with personal protective equipment during the COVID-19 pandemic in the UK: a rapid qualitative appraisal. BMJ Open. 2021 11 ;e046199.
  • Ranney ML, Griffeth V, Jha AK. Critical Supply Shortages — the Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med. 2020;382(18):e41.
  • Verbeek JH, Ijaz S, and Mischke C et al, Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst. Rev 2016 4 (4) CD011621 .
  • Noor M, Haq M, and Ul Haq N et al, Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2? Cureus. 2020 12 (11) e11389.
  • WHO Classifying health workers: mapping occupations to the international standard classification [internet] . . : 2008 [cited18 May 2021] https://www.who.int/hrh/statistics/Health_workers_classification.pdf.
  • Vashist SK. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics. 2020 10 (4) ;202.
  • Weissleder R, Lee H, and Ko J, COVID-19 diagnostics in context. Sci. Transl. Med. 2020 12 eabc1931 .
  • Zhao J, Yuan Q, Wang H, et al. Antibody Responses to SARS-CoV-2 in Patients with Novel Coronavirus Disease 2019. Clin Infect Dis. 2020;71(16):2027–2034.
  • Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489–493.
  • Stephens DS, Mj M. COVID-19 and the Path to Immunity. J Am Med Assoc. 2020;324(13):1279–1281.
  • Murchu E O, Byrne P, and Ka W, et al. Immune response following infection with SARS-CoV-2 and other coronaviruses: a rapid review. Rev Med Virol. 2021 31 ;e2162.
  • Deeks JJ, Dinnes J, and Takwoingi Y et al Antibody tests for identification of current and past infection with SARS-CoV-2 , Cochrane Database Syst Rev. 2020 6 (6) CD013652 .
  • Bohn MK, Loh TP, Bin WC, et al. IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2. Clin Chem Lab Med. 2020;58(12):2001–2008.
  • Chou R, Dana T, Buckley DI, et al. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: a Living Rapid Review. Ann Intern Med. 2020;173(2):120–136.
  • Mehta S, Machado F, Kwizera A, et al. COVID-19: a heavy toll on health-care workers. Lancet Respir Med. 2021;9(3):226–228.
  • Pappa S, Ntella V, Giannakas T, et al. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun. 2020;88:901–907.
  • Scozzari G, Costa C, Migliore E, et al. Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy. Viruses. 2021;13(6):1064.
  • Sciensano. Belgium COVID-19 Studies: seroprevalence [Internet]. [cited 1 June 2021] Available from: https://datastudio.google.com/embed/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB.
  • Vivier E, Pariset C, Rio S, et al. Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital. Ann Intensive Care. 2021;11(1):75.
  • Shields A, Faustini SE, Perez-Toledo M, et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020;75(12):1089–1094.
  • Ensuring sufficient physical infrastructure and workforce capacity [ Internet]. [ cited 2021 Jun 4]. Available from: https://www.covid19healthsystem.org/countries/belgium/livinghit.aspx?Section=2.1Physicalinfrastructure&Type=Section.
  • Ran L, Chen X, Wang Y, et al. Risk Factors of Healthcare Workers with Coronavirus Disease 2019: a Retrospective Cohort Study in a Designated Hospital of Wuhan in China. Clin Infect Dis. 2020;71(16):2218–2221.
  • Lai X, Wang M, and Qin C, et al. Coronavirus Disease 2019 (COVID-2019) Infection among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Network Open. 2020 3 (5) ;e209666.
  • Vaira LA, Salzano G, Deiana G, et al. Anosmia and Ageusia: common Findings in COVID-19 Patients. Laryngoscope. 2020;130(7):1787.
  • Bénézit F, Le Turnier P, Declerck C, et al. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. Lancet Infect Dis. 2020;20(9):1014–1015.
  • Steensels D, Oris E, and Coninx L et al, Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. JAMA 2020 342 (2) 195–197.
  • Seow J, Graham C, Merrick B, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5(12):1598–1607.
  • Lumley SF, Wei J, O’Donnell D, et al. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers. Clin Infect Dis. 2021;73(3):e699–e709.
  • Favresse J, Eucher C, Elsen M, et al. Persistence of anti-sars-cov-2 antibodies depends on the analytical kit: a report for up to 10 months after infection. Microorganisms. 2021;9(3):1–13.
  • Irsara C, Egger AE, and Prokop W, et al. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay. Clin Chem Lab Med. 2021 59 (6) ;1143–1154.
  • Favresse J, Bayart J-L, Mullier F, et al. Early antibody response in healthcare professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021;27(9):1351.e5–1351.e7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.